Your browser doesn't support javascript.
loading
Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India's public sector.
Lee, David J; Kumarasamy, Nagalingeswaran; Resch, Stephen C; Sivaramakrishnan, Gomathi N; Mayer, Kenneth H; Tripathy, Srikanth; Paltiel, A David; Freedberg, Kenneth A; Reddy, Krishna P.
Afiliação
  • Lee DJ; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Kumarasamy N; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
  • Resch SC; Chennai Antiviral Research and Treatment Clinical Research Site, Voluntary Health Services, Chennai, India.
  • Sivaramakrishnan GN; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Mayer KH; Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Tripathy S; National Institute for Research in Tuberculosis, Chennai, India.
  • Paltiel AD; Harvard Medical School, Boston, Massachusetts, United States of America.
  • Freedberg KA; The Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America.
  • Reddy KP; Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
PLoS One ; 14(7): e0218890, 2019.
Article em En | MEDLINE | ID: mdl-31265470
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Análise Custo-Benefício / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Análise Custo-Benefício / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2019 Tipo de documento: Article